Reproducibility study on non-small cell lung cancer specimens stained with PD-L1 IHC 22C3 pharmDx (Dako Omnis, GE006)

被引：0
|
作者：
Musser, J. [1 ]
Toland, G. [1 ]
Roach, C. [1 ]
Tabuena-Frolli, S. [1 ]
Hund, S. [1 ]
机构：
[1] Agilent Technol, Santa Clara, CA USA
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-20-04
引用
收藏
页码：S446 / S446
页数：1
相关论文
共 50 条
  • [1] Validation studies of PD-L1 IHC 22C3 pharmDx (Dako Omnis) for human non-small cell lung carcinoma (NSCLC) tissues
    Kramer, L.
    Toland, G.
    O'Brien, J.
    Roach, C.
    Welcher, R.
    Kulangara, K.
    VIRCHOWS ARCHIV, 2019, 475 : S139 - S140
  • [2] Inter-assay comparison of two PD-L1 IHC 22C3 pharmDx Assays for Dako Autostainer Link 48 (SK006) and Omnis (GE006) in different cancer types
    Kristoffersen, H. L.
    Roge, R.
    Nielsen, S.
    VIRCHOWS ARCHIV, 2024, 485 : S343 - S343
  • [3] PD-L1 IHC 22C3 pharmDx: Analytical validation on cervical cancer specimens
    Musser, J.
    Evans, T.
    Posch, A.
    Vasquez, J.
    Tabuena-Frolli, S.
    Apostolaki, A.
    Kulangara, K.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S109 - S109
  • [4] A Comparative Study of PD-L1 IHC 28-8 pharmDx and PD-L1 IHC 22C3 pharmDx on Malignancies from the Lung
    Skov, Birgit
    Skov, Torsten
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S815 - S816
  • [5] Impact of prolonged ischemia and fixation time on tonsil specimens stained with PD-L1 IHC 22C3 pharmDx
    Roach, C.
    Kersch, K.
    Musser, J.
    Tabuena-Frolli, S.
    Hund, S.
    Kulangara, K.
    VIRCHOWS ARCHIV, 2024, 485 : S347 - S347
  • [6] A comparative study of "PD-L1-CAD-test" (BIOCAD) and "PD-L1 IHC 22C3 pharmDx Kit" (Dako)
    Frank, G.
    Kuznetsova, O.
    Zavalishina, L.
    Andreeva, Y.
    Moskvina, L.
    VIRCHOWS ARCHIV, 2019, 475 : S101 - S102
  • [7] External Reproducibility of PD-L1 IHC 22C3 pharmDx on Breast Cancer Specimens at CPS ≥ 1 and CPS ≥ 10 Cutoffs
    Steiner, Lori
    Barreto, Joseph
    Olander, Emily
    Kell, Donna
    Tabuena-Frolli, Siena
    Polewski, Monika
    CANCER RESEARCH, 2024, 84 (09)
  • [8] Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
    Fujimoto, Daichi
    Yamashita, Daisuke
    Fukuoka, Junya
    Kitamura, Yuka
    Hosoya, Kazutaka
    Kawachi, Hayato
    Sato, Yuki
    Nagata, Kazuma
    Nakagawa, Atsushi
    Tachikawa, Ryo
    Date, Naoki
    Sakanoue, Ichiro
    Hamakawa, Hiroshi
    Takahashi, Yutaka
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2018, 38 (12) : 6891 - 6895
  • [9] Comparison of PD-L1 Expression Using 2 Validated PD-L1 IHC 22C3 pharmDx Methods in Non-Small Cell Lung Cancer in a Routine Hospital Setting
    Skov, Birgit G.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (01) : 49 - 55
  • [10] EXTERNAL REPRODUCIBILITY OF PD-L1 IHC 22C3 PHARMDX FOR CERVICAL CANCER AT CPS ≥ 1 AND CPS ≥ 10
    Cherryholmes, Greg
    Posch, Alexander
    Tabuena-Frolli, Siena
    Vasquez, Jesse
    Evans, Tiffany
    La Placa, Chris
    Kersch, Kristopher
    Apostolaki, Angeliki
    Juco, Jonathan
    Kulangara, Karina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A44 - A44
12345